Contineum Therapeutics, Inc. Class A Common Stock

CTNM · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$21,943$15,526$5,569$4,630
Short-Term Investments$182,817$109,664$41,670$64,374
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,628$2,516$1,153$775
Total Curr. Assets$206,388$127,706$48,392$69,779
Property Plant & Equip (Net)$6,456$1,397$2,115$642
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$3$1,283$129$97
Total NC Assets$6,459$2,680$2,244$739
Other Assets$0$0$0$0
Total Assets$212,847$130,386$50,636$70,518
Liabilities
Payables$1,811$635$430$660
Short-Term Debt$1,452$464$5,058$1,250
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$6,711$4,385$2,062$1,764
Total Curr. Liab.$9,974$5,484$7,550$3,674
LT Debt$4,807$192,728$791$3,659
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$110$3,025$1,597
Total NC Liab.$4,807$192,838$3,816$5,256
Other Liabilities$0$0$0$0
Cap. Leases$6,259$572$1,901$0
Total Liabilities$14,781$198,322$11,366$8,930
Equity
Pref Stock$0$0$132,482$132,482
Common Stock$26$2$12$12
Retained Earnings-$117,402-$75,144-$97,864-$73,611
AOCI$71$108-$76-$35
Other Equity$315,371$7,098$4,716$2,740
Total Equity$198,066-$67,936$39,270$61,588
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$212,847$130,386$50,636$70,518
Net Debt-$15,684$177,666$280$279
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Financial Statements & Key Stats | AlphaPilot